Logo image of NOVC.DE

(NOVC.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:NOVC - DK0060534915 - Common Stock

86.34 EUR
-2.03 (-2.3%)
Last: 9/19/2023, 5:26:42 PM
Fundamental Rating

6

Overall NOVC gets a fundamental rating of 6 out of 10. We evaluated NOVC against 53 industry peers in the Pharmaceuticals industry. NOVC has an excellent profitability rating, but there are some minor concerns on its financial health. NOVC is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes NOVC very considerable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year NOVC was profitable.
  • In the past year NOVC had a positive cash flow from operations.
NOVC.DE Yearly Net Income VS EBIT VS OCF VS FCFNOVC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 20B 40B 60B

1.2 Ratios

  • NOVC's Return On Assets of 23.95% is amongst the best of the industry. NOVC outperforms 95.56% of its industry peers.
  • The Return On Equity of NOVC (74.32%) is better than 95.56% of its industry peers.
  • The Return On Invested Capital of NOVC (55.96%) is better than 97.78% of its industry peers.
  • NOVC had an Average Return On Invested Capital over the past 3 years of 49.65%. This is significantly above the industry average of 14.02%.
  • The 3 year average ROIC (49.65%) for NOVC is below the current ROIC(55.96%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 23.95%
ROE 74.32%
ROIC 55.96%
ROA(3y)25.55%
ROA(5y)28.51%
ROE(3y)66.85%
ROE(5y)68.54%
ROIC(3y)49.65%
ROIC(5y)55.99%
NOVC.DE Yearly ROA, ROE, ROICNOVC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 33.40%, NOVC belongs to the top of the industry, outperforming 91.11% of the companies in the same industry.
  • NOVC's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 42.80%, NOVC belongs to the best of the industry, outperforming 95.56% of the companies in the same industry.
  • In the last couple of years the Operating Margin of NOVC has remained more or less at the same level.
  • With an excellent Gross Margin value of 84.35%, NOVC belongs to the best of the industry, outperforming 84.44% of the companies in the same industry.
  • NOVC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 42.8%
PM (TTM) 33.4%
GM 84.35%
OM growth 3Y-0.97%
OM growth 5Y-0.64%
PM growth 3Y-0.57%
PM growth 5Y-1.67%
GM growth 3Y-0.02%
GM growth 5Y-0.07%
NOVC.DE Yearly Profit, Operating, Gross MarginsNOVC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 20 40 60 80

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NOVC is creating value.
  • NOVC has less shares outstanding than it did 1 year ago.
  • NOVC has a better debt/assets ratio than last year.
NOVC.DE Yearly Shares OutstandingNOVC.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B
NOVC.DE Yearly Total Debt VS Total AssetsNOVC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50B 100B 150B 200B

2.2 Solvency

  • An Altman-Z score of 11.18 indicates that NOVC is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of NOVC (11.18) is better than 93.33% of its industry peers.
  • The Debt to FCF ratio of NOVC is 0.38, which is an excellent value as it means it would take NOVC, only 0.38 years of fcf income to pay off all of its debts.
  • NOVC has a Debt to FCF ratio of 0.38. This is amongst the best in the industry. NOVC outperforms 91.11% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that NOVC is not too dependend on debt financing.
  • NOVC has a Debt to Equity ratio of 0.21. This is comparable to the rest of the industry: NOVC outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.38
Altman-Z 11.18
ROIC/WACC7.69
WACC7.28%
NOVC.DE Yearly LT Debt VS Equity VS FCFNOVC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 20B 40B 60B 80B

2.3 Liquidity

  • A Current Ratio of 0.88 indicates that NOVC may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.88, NOVC is doing worse than 84.44% of the companies in the same industry.
  • A Quick Ratio of 0.70 indicates that NOVC may have some problems paying its short term obligations.
  • NOVC has a worse Quick ratio (0.70) than 82.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.7
NOVC.DE Yearly Current Assets VS Current LiabilitesNOVC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20B 40B 60B 80B 100B

7

3. Growth

3.1 Past

  • The earnings per share for NOVC have decreased strongly by -32.68% in the last year.
  • NOVC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.48% yearly.
  • The Revenue has grown by 28.03% in the past year. This is a very strong growth!
  • The Revenue has been growing by 9.64% on average over the past years. This is quite good.
EPS 1Y (TTM)-32.68%
EPS 3Y3.69%
EPS 5Y3.48%
EPS Q2Q%-26.37%
Revenue 1Y (TTM)28.03%
Revenue growth 3Y13.19%
Revenue growth 5Y9.64%
Sales Q2Q%31.59%

3.2 Future

  • NOVC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.79% yearly.
  • NOVC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.65% yearly.
EPS Next Y96.77%
EPS Next 2Y52.67%
EPS Next 3Y40.31%
EPS Next 5Y25.79%
Revenue Next Year27.56%
Revenue Next 2Y22.92%
Revenue Next 3Y20.4%
Revenue Next 5Y13.65%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NOVC.DE Yearly Revenue VS EstimatesNOVC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B 400B
NOVC.DE Yearly EPS VS EstimatesNOVC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20 40 60 80

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 43.17 indicates a quite expensive valuation of NOVC.
  • Based on the Price/Earnings ratio, NOVC is valued a bit more expensive than the industry average as 64.44% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 27.54, NOVC is valued quite expensively.
  • A Price/Forward Earnings ratio of 15.13 indicates a correct valuation of NOVC.
  • Based on the Price/Forward Earnings ratio, NOVC is valued a bit cheaper than 64.44% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.31. NOVC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 43.17
Fwd PE 15.13
NOVC.DE Price Earnings VS Forward Price EarningsNOVC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NOVC is valued a bit more expensive than 64.44% of the companies in the same industry.
  • NOVC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 42.68
EV/EBITDA 30.33
NOVC.DE Per share dataNOVC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • NOVC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NOVC has a very decent profitability rating, which may justify a higher PE ratio.
  • NOVC's earnings are expected to grow with 40.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)12.41
EPS Next 2Y52.67%
EPS Next 3Y40.31%

0

5. Dividend

5.1 Amount

  • No dividends for NOVC!.
Industry RankSector Rank
Dividend Yield N/A

FRA:NOVC (9/19/2023, 5:26:42 PM)

86.34

-2.03 (-2.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap386.28B
Revenue(TTM)201.32B
Net Income(TTM)67.24B
Analysts70.63
Price Target169.94 (96.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP41.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.26%
Min EPS beat(2)-6.63%
Max EPS beat(2)2.11%
EPS beat(4)3
Avg EPS beat(4)-0.09%
Min EPS beat(4)-6.63%
Max EPS beat(4)2.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)99180.3%
Min Revenue beat(2)97265.9%
Max Revenue beat(2)101095%
Revenue beat(4)4
Avg Revenue beat(4)100079%
Min Revenue beat(4)97265.9%
Max Revenue beat(4)101151%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.68%
PT rev (3m)6.75%
EPS NQ rev (1m)-50.34%
EPS NQ rev (3m)-49.42%
EPS NY rev (1m)0.22%
EPS NY rev (3m)4.6%
Revenue NQ rev (1m)-99.9%
Revenue NQ rev (3m)-99.9%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)3.71%
Valuation
Industry RankSector Rank
PE 43.17
Fwd PE 15.13
P/S 14.31
P/FCF 42.68
P/OCF 32.1
P/B 31.84
P/tB 72.51
EV/EBITDA 30.33
EPS(TTM)2
EY2.32%
EPS(NY)5.71
Fwd EY6.61%
FCF(TTM)2.02
FCFY2.34%
OCF(TTM)2.69
OCFY3.12%
SpS6.03
BVpS2.71
TBVpS1.19
PEG (NY)0.45
PEG (5Y)12.41
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 23.95%
ROE 74.32%
ROCE 69.41%
ROIC 55.96%
ROICexc 79.18%
ROICexgc 187.85%
OM 42.8%
PM (TTM) 33.4%
GM 84.35%
FCFM 33.53%
ROA(3y)25.55%
ROA(5y)28.51%
ROE(3y)66.85%
ROE(5y)68.54%
ROIC(3y)49.65%
ROIC(5y)55.99%
ROICexc(3y)59.43%
ROICexc(5y)70.56%
ROICexgc(3y)107.14%
ROICexgc(5y)103.87%
ROCE(3y)66.16%
ROCE(5y)72.5%
ROICexgc growth 3Y12.28%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.96%
ROICexc growth 5Y-9.74%
OM growth 3Y-0.97%
OM growth 5Y-0.64%
PM growth 3Y-0.57%
PM growth 5Y-1.67%
GM growth 3Y-0.02%
GM growth 5Y-0.07%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.38
Debt/EBITDA 0.21
Cap/Depr 278.9%
Cap/Sales 11.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 100.38%
Current Ratio 0.88
Quick Ratio 0.7
Altman-Z 11.18
F-Score7
WACC7.28%
ROIC/WACC7.69
Cap/Depr(3y)235.6%
Cap/Depr(5y)244.27%
Cap/Sales(3y)10.33%
Cap/Sales(5y)10.26%
Profit Quality(3y)95.36%
Profit Quality(5y)92.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-32.68%
EPS 3Y3.69%
EPS 5Y3.48%
EPS Q2Q%-26.37%
EPS Next Y96.77%
EPS Next 2Y52.67%
EPS Next 3Y40.31%
EPS Next 5Y25.79%
Revenue 1Y (TTM)28.03%
Revenue growth 3Y13.19%
Revenue growth 5Y9.64%
Sales Q2Q%31.59%
Revenue Next Year27.56%
Revenue Next 2Y22.92%
Revenue Next 3Y20.4%
Revenue Next 5Y13.65%
EBIT growth 1Y29.73%
EBIT growth 3Y12.1%
EBIT growth 5Y8.94%
EBIT Next Year38.11%
EBIT Next 3Y23.19%
EBIT Next 5Y17.5%
FCF growth 1Y112.16%
FCF growth 3Y21.73%
FCF growth 5Y14.55%
OCF growth 1Y65.59%
OCF growth 3Y19.03%
OCF growth 5Y13.89%

/ NOVC.DE FAQ

What is the fundamental rating for NOVC stock?

ChartMill assigns a fundamental rating of 7 / 10 to NOVC.DE.


What is the valuation status of (NOVC.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to (NOVC.DE). This can be considered as Fairly Valued.


How profitable is (NOVC.DE) stock?

(NOVC.DE) has a profitability rating of 9 / 10.


What is the financial health of (NOVC.DE) stock?

The financial health rating of (NOVC.DE) is 7 / 10.


How sustainable is the dividend of (NOVC.DE) stock?

The dividend rating of (NOVC.DE) is 4 / 10 and the dividend payout ratio is 41.57%.